Who has invested in Oncternal Therapeutics?

No investors are named on the public record for Oncternal Therapeutics yet.

Oncternal Therapeutics Funding: $18M Raised, Series B (2017)

Oncternal Therapeutics funding overview

Oncternal Therapeutics is based in San Diego. Oncternal Therapeutics has raised $18M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in February 2017. The round record for Oncternal Therapeutics runs through 2017; nothing later has been disclosed.

Oncternal Therapeutics at a glance

Total raised: $18M
Latest round: Series B
Latest round date: February 2017
Headquarters: San Diego

Frequently asked about Oncternal Therapeutics funding

How much has Oncternal Therapeutics raised?: Oncternal Therapeutics has raised $18M in total disclosed funding across the rounds on record.
Who has invested in Oncternal Therapeutics?: No investors are named on the public record for Oncternal Therapeutics yet.
What was the latest Oncternal Therapeutics funding round?: The most recent disclosed round is a Series B, announced in February 2017.
Where is Oncternal Therapeutics based?: Oncternal Therapeutics is based in San Diego.
When did Oncternal Therapeutics last raise?: The last disclosed Oncternal Therapeutics round closed in February 2017 at Series B.

Oncternal Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Oncternal Therapeutics Funding: $18M Raised, Series B (2017)

Oncternal Therapeutics funding overview

Oncternal Therapeutics at a glance

Frequently asked about Oncternal Therapeutics funding

Companies related to Oncternal Therapeutics (18)

Browse related funding lists (5)